Department of Epidemiology, Istituto di Ricerche Farmacologiche 'Mario Negri'; Institute of Medical Statistics and Biometry 'G.A. Maccacaro', Università degli Studi di Milano, Milan, Italy.
Department of Epidemiology, Istituto di Ricerche Farmacologiche 'Mario Negri'.
Ann Oncol. 2010 Jun;21(6):1323-1360. doi: 10.1093/annonc/mdp530. Epub 2009 Nov 30.
To update the pattern of cancer mortality in Europe.
We analysed cancer mortality in 34 European countries during 2000-2004, with an overview of trends in 1975-2004 using data from the World Health Organization.
From 1990-1994 to 2000-2004, overall cancer mortality in the European Union declined from 185.2 to 168.0/100 000 (world standard, -9%) in men and from 104.8 to 96.9 (-8%) in women, with larger falls in middle age. Total cancer mortality trends were favourable, though to a variable degree, in all major European countries, including Russia, but not in Romania. The major determinants of these favourable trends were the decline of lung (-16%) and other tobacco-related cancers in men, together with the persistent falls in gastric cancer, and the recent appreciable falls in colorectal cancer. In women, relevant contributions came from the persistent decline in cervical cancer and the recent falls in breast cancer mortality, particularly in northern and western Europe. Favourable trends were also observed for testicular cancer, Hodgkin lymphomas, leukaemias, and other neoplasms amenable to treatment, though the reductions were still appreciably smaller in eastern Europe.
This updated analysis of cancer mortality in Europe showed a persistent favourable trend over the last years.
更新欧洲癌症死亡率模式。
我们分析了 2000-2004 年期间 34 个欧洲国家的癌症死亡率，并使用世界卫生组织的数据对 1975-2004 年的趋势进行了概述。
从 1990-1994 年到 2000-2004 年，欧盟男性的总体癌症死亡率从 185.2 下降到 168.0/100000（世界标准，下降 9%），女性从 104.8 下降到 96.9（下降 8%），中年下降幅度更大。除罗马尼亚以外，所有主要欧洲国家，包括俄罗斯，总体癌症死亡率趋势都朝着有利的方向发展，尽管程度不同。这些有利趋势的主要决定因素是男性肺癌（-16%）和其他与烟草相关的癌症下降，同时胃癌持续下降，以及结直肠癌最近明显下降。在女性中，宫颈癌持续下降和乳腺癌死亡率最近下降也做出了重要贡献，尤其是在北欧和西欧。睾丸癌、霍奇金淋巴瘤、白血病和其他可治疗的肿瘤也出现了有利趋势，尽管东欧的降幅仍然明显较小。
这项对欧洲癌症死亡率的最新分析表明，近年来一直保持着有利的趋势。
